Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry.
about
Pharmacological management of IPFRe-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis.Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registryPulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias.Burden of Idiopathic Pulmonary Fibrosis Progression: A 5-Year Longitudinal Follow-Up Study.TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary FibrosisImpact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary FibrosisIdiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations.Effect of Nintedanib in Subgroups of Idiopathic Pulmonary Fibrosis by Diagnostic Criteria.Body mass index-percent forced vital capacity-respiratory hospitalization: new staging for idiopathic pulmonary fibrosis patients.Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis.What patients with pulmonary fibrosis and their partners think: a live, educative survey in the Netherlands and Germany.Managing Idiopathic Pulmonary Fibrosis: Which Drug for Which Patient?Hypersensitivity Pneumonitis: Perspectives in Diagnosis and Management.Optimizing quality of life in patients with idiopathic pulmonary fibrosis.Utility of Transbronchial vs Surgical Lung Biopsy in the Diagnosis of Suspected Fibrotic Interstitial Lung Disease.The safety and tolerability of nintedanib in the treatment of idiopathic pulmonary fibrosis.Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume.Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris.Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases: Rationale, Aims, and Design of a Nationwide Prospective Registry--The EXCITING-ILD Registry.Recent advances in managing idiopathic pulmonary fibrosis.Amnion Epithelial Cell-Derived Exosomes Restrict Lung Injury and Enhance Endogenous Lung Repair.Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia.The Importance of Sex Stratification in Autoimmune Disease Biomarker Research: A Systematic Review.Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trialsInterpretation of HRCT Scans in the Diagnosis of IPF: Improving Communication Between Pulmonologists and Radiologists
P2860
Q26748808-ACE929BF-3D28-463D-AC1C-10013422CA3DQ30987980-F815508A-B2ED-42E3-83C6-79E479BE406AQ33908569-5B2ACA43-3BE0-41C9-AFB5-7AF7014366BDQ35858996-B7B5D94E-186A-4F6A-8F0F-7F1F04FAF803Q36252622-6A030F2A-BCBA-45EF-9F53-25E6F3A7EF5EQ36516894-2836E98B-38CF-4254-A2EB-2E12203082ACQ36739149-E568CE89-A6A6-4514-AF10-D191796AAC00Q37237739-81E970B3-9F45-4BB8-BC30-C8E966F87C24Q37559606-B63A3CFF-21CF-4CB3-843E-AF28ABBAC8E1Q37581188-A2473B08-FBEE-4758-A7CE-62CC975E413AQ37616955-E4BBC9CE-016F-4FD4-A29D-A306F16154B5Q37641221-1E1EE05D-8912-447D-8DAB-2C7AD1AFD804Q38598382-9CDA0E57-6BC5-461E-9696-FA2F2DD666B8Q38672927-C43555D9-BC14-4367-BCF8-3BFBFA4E699BQ39108878-0E57D054-0F69-403D-9CB3-A3FC46950930Q39301813-E5DCD128-2F4D-4F55-B91B-16BE6F9524A1Q39344375-470C3F0F-4D75-4DCE-BBD5-FFD01C6BE3BCQ39348154-4A2FC94C-D05A-4483-8EB5-590BFF7AC2FCQ40095447-5FAD876B-43FD-49BE-8BA3-46DC4F555CB0Q40238886-4AF73B89-ABC2-422B-AE30-88A0246C6387Q47157713-3C707AF2-B743-4827-AE5C-D4613CCC86AEQ47235420-9E7A28AF-6F53-408A-895A-95E1E66BCF5AQ47791471-B0A93446-AA87-43DA-BB6A-513A91E4DA5AQ55334988-B8A7512C-4EF5-455B-89D5-D9F5EBE014E0Q58768071-D13D19BD-1AB2-4CDC-BBDB-59961E4DD64BQ58788821-C973B33B-6E3D-4303-A912-957E0386128B
P2860
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Management of patients with id ...... ce: the INSIGHTS-IPF registry.
@ast
Management of patients with id ...... ce: the INSIGHTS-IPF registry.
@en
type
label
Management of patients with id ...... ce: the INSIGHTS-IPF registry.
@ast
Management of patients with id ...... ce: the INSIGHTS-IPF registry.
@en
prefLabel
Management of patients with id ...... ce: the INSIGHTS-IPF registry.
@ast
Management of patients with id ...... ce: the INSIGHTS-IPF registry.
@en
P2093
P2860
P1476
Management of patients with id ...... ce: the INSIGHTS-IPF registry.
@en
P2093
Andrea Koch
Christian Grohé
Claus Neurohr
David Pittrow
Dirk Koschel
Dirk Skowasch
F Joachim Meyer
Felix J F Herth
Gert Höffken
Henrike Wilkens
P2860
P304
P356
10.1183/09031936.00217614
P577
2015-04-02T00:00:00Z